InsiderTrades

Form 4 for NBIX NEUROCRINE BIOSCIENCES INC

Accepted 2024-08-15 00:00:00 ET · period of report 2024-08-13 · accession 0000914475-24-000195 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-08-15 2024-08-13 NBIX LYONS GARY A Dir M - OptEx $42.76 +11.6K 130.6K +10% +$494.7K
D 2024-08-15 2024-08-13 NBIX LYONS GARY A Dir S - Sale+OE $150.43 -11.6K 119.0K -9% -$1.74M
D 2024-08-15 2024-08-13 NBIX LYONS GARY A Dir M - OptEx $0.00 -11.6K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-08-13 M A 11,570 $42.76 130,617 D — — (F1) 113,064 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power.
2 Common Common Stock 2024-08-13 S D 11,570 $150.43 119,047 D — — (F3) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $151.30. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range (F1) 113,064 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power.
3 Derivative Non-Qualified Stock Option 2024-08-13 M D 11,570 $0.00 0 D $42.76 · — to 2025-05-28 11,570 Common Stock (F4) The option was granted May 28, 2015 and vested in 12 equal monthly installments beginning June 28, 2015. These options will expire ten years from the date of grant on May 28, 2025.